Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis

Nano‐immunotherapy regimens have high potential to improve patient outcomes, as already demonstrated in advanced triple negative breast cancer with nanoparticle albumin‐bound paclitaxel and the immune checkpoint blocker (ICB) atezolizumab. This regimen, however, does not lead to cures with median su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mpekris, Fotios, Panagi, Myrofora, Voutouri, Chrysovalantis, Martin, John D., Samuel, Rekha, Takahashi, Shinichiro, Gotohda, Naoto, Suzuki, Toshiyuki, Papageorgis, Panagiotis, Demetriou, Philippos, Pierides, Chryso, Koumas, Laura, Costeas, Paul, Kojima, Motohiro, Ishii, Genichiro, Constantinidou, Anastasia, Kataoka, Kazunori, Cabral, Horacio, Stylianopoulos, Triantafyllos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856901/
https://www.ncbi.nlm.nih.gov/pubmed/33552852
http://dx.doi.org/10.1002/advs.202001917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856901/
https://www.ncbi.nlm.nih.gov/pubmed/33552852
http://dx.doi.org/10.1002/advs.202001917

Ejemplares similares